Home › Psoriatic Arthritis › North Carolina
Psoriatic Arthritis clinical trials in North Carolina
11 studies for Psoriatic Arthritis are looking for participants at sites in North Carolina.
Cities in North Carolina
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- Joint and Muscle Research Institute, Charlotte
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06807424A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Joint and Muscle Research Institute, Charlotte
- Onsite Clinical Solutions, Salisbury
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07321873A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 106, Chapel Hill
- Up0122 102, Durham
RecruitingPhase 1
Ages 18 and older · Women · Updated Sep 18, 2026 · NCT06888193A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Accellacare of Hickory, Hickory
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Joint and Muscle Research Institute ( Site 5108), Charlotte
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 14, 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Charlotte
- Clinical Site, Leland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- DJL Clinical Research | Charlotte, NC, Charlotte
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06671496A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- University of North Carolina - Children's Hospital /ID# 259286, Chapel Hill
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 4
Ages 18 and older · Women · Updated Aug 28, 2026 · NCT07654751Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital / Carolinas Medical Center, Charlotte
- Duke Children's Hospital & Health Center, Durham
- and 1 more
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- Evidera, a PPD Business Unit /ID# 238688, Morrisville
RecruitingObservational study
All ages · Women · Updated Jul 17, 2025 · NCT04846959From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.